Please use this identifier to cite or link to this item:
Title: Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.
Authors: O'Gorman, N
Wright, D
Poon, L C
Rolnik, D L
Syngelaki, A
Wright, A
Akolekar, R
Cicero, S
Janga, D
Jani, J
Molina, F S
de Paco Matallana, C
Papantoniou, N
Persico, N
Plasencia, W
Singh, M
Nicolaides, K H
Keywords: Bayes' theorem;first-trimester screening;mean arterial pressure;placental growth factor;pre-eclampsia;pregnancy-associated plasma protein-A;pyramid of pregnancy care;survival model;uterine artery Doppler
metadata.dc.subject.mesh: Adult
Gestational Age
Models, Theoretical
Placenta Growth Factor
Pregnancy Trimester, First
Prenatal Diagnosis
Prospective Studies
Pulsatile Flow
Risk Assessment
Sensitivity and Specificity
Uterine Artery
Issue Date: 14-May-2017
Abstract: To examine the diagnostic accuracy of a previously developed model for prediction of pre-eclampsia (PE) by a combination of maternal factors and biomarkers at 11-13 weeks' gestation. This was a prospective first-trimester multicenter study of screening for PE in 8775 singleton pregnancies. A previously published algorithm was used for the calculation of patient-specific risk of PE in each individual. The detection rates (DRs) and false-positive rates (FPRs) for delivery with PE In the study population, 239 (2.7%) cases developed PE, of which 17 (0.2%), 59 (0.7%) and 180 (2.1%) developed PE Assessment of a combination of maternal factors and biomarkers at 11-13 weeks provides effective first-trimester screening for preterm PE. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.
metadata.dc.identifier.doi: 10.1002/uog.17399
Appears in Collections:Producción 2020

Files in This Item:
There are no files associated with this item.

This item is protected by original copyright

Except where otherwise noted, Items on the Andalusian Health Repository site are licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives License.